AndroGel verdict: $140 million in Low Testosterone heart attack trial against Abbvie

A man who suffered a heart attack while using AndroGel received a $140 million jury verdict in his favor in the latest damaging news for AbbVie, manufacturer of the testosterone therapy drug.

Jones Ward PLC represents men all over the country who took so-called “Low T” drugs because they were told the product would give them energy, increase their sex drive and make them feel young again. But thousands of men later suffered blood clots, heart attacks and other injuries, and there are now more than 6,000 lawsuits pending against companies such as Abbvie, Eli Lilly, Auxilium, and Pfizer. The cases are part of a consolidated proceeding in federal court called Multidistrict Litigation, or MDL for short. The Low T cases are consolidated in U.S. District Court in Northern Illinois.

Testosterone Therapy Injury Overview

Lawyers for Jeffrey Konrad, the plaintiff in  the latest trial, argued that Abbvie’s aggressive marketing tactics put Konrad’s safety at risk. He had a heart attack just a few months after starting Androgel treatment. Abbyie failed to warn him and other users that Androgel put him at risk for heart attacks and other injuries, he argued, and the jury agreed.

AndroGel is approved to treat a condition called hypogonadism, which is caused by abnormally low levels of testosterone. But as part of the normal aging process, male testosterone levels naturally decrease over the years. Some older men were lead to believe they suffered from a disease that could be “cured” by products such as Androgel, Testim, Axiron, and Foresta.  The testosterone trial lawyers at Jones Ward PLC have heard stories from countless men who had strokes, heart attacks, deep vein thrombosis (blood clots in the leg) and pulmonary embolism (blood clots in the lung).

Studies from the U.S. Food and Drug Administration (FDA) show a 30% to 290% increased risk of cardiovascular events for certain users of Low T drugs.
Free Case Evaluation

The attorneys at Jones Ward PLC are currently investigating claims against the makers of testosterone therapies such as AndroGel, Testim, and Axiron. To learn more about these drugs and your potential legal claim, visit our Low T Information page. If you suffered an injury while taking testosterone therapy, contact attorney Alex C. Davis at 502-882-6000 for a free case evaluation, or send an email to alex@jonesward.com for more information.

Sorry, comments are closed for this post.